Thomas Licht

2.4k total citations
63 papers, 1.8k citations indexed

About

Thomas Licht is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Thomas Licht has authored 63 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 28 papers in Molecular Biology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Thomas Licht's work include Drug Transport and Resistance Mechanisms (20 papers), RNA Interference and Gene Delivery (10 papers) and Cancer therapeutics and mechanisms (9 papers). Thomas Licht is often cited by papers focused on Drug Transport and Resistance Mechanisms (20 papers), RNA Interference and Gene Delivery (10 papers) and Cancer therapeutics and mechanisms (9 papers). Thomas Licht collaborates with scholars based in Germany, United States and Austria. Thomas Licht's co-authors include Ira Pastan, Michael M. Gottesman, M M Gottesman, Christian Peschel, F. Herrmann, Carol Cardarelli, Timothy C. Chambers, Suresh V. Ambudkar, Ursula A. Germann and Ralf Wienecke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Thomas Licht

62 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Licht Germany 23 757 715 226 215 195 63 1.8k
Andrew L. Gilman United States 25 771 1.0× 750 1.0× 139 0.6× 136 0.6× 228 1.2× 60 2.8k
E Archimbaud France 34 2.3k 3.1× 1.4k 1.9× 272 1.2× 199 0.9× 210 1.1× 124 5.1k
Martin Höglund Sweden 37 1.5k 1.9× 1.2k 1.7× 206 0.9× 60 0.3× 257 1.3× 134 5.1k
Michael Loughnan Australia 11 1.2k 1.6× 602 0.8× 251 1.1× 168 0.8× 90 0.5× 24 2.7k
Giuliana Alimena Italy 34 1.0k 1.4× 667 0.9× 219 1.0× 59 0.3× 277 1.4× 206 4.7k
Tanya Trippett United States 24 580 0.8× 655 0.9× 263 1.2× 68 0.3× 96 0.5× 79 1.9k
Hiroaki Goto Japan 22 485 0.6× 364 0.5× 124 0.5× 106 0.5× 130 0.7× 157 1.7k
Michael E. Ross United States 13 560 0.7× 1.0k 1.4× 364 1.6× 181 0.8× 123 0.6× 26 1.9k
P H Wiernik United States 23 369 0.5× 847 1.2× 318 1.4× 214 1.0× 76 0.4× 70 1.8k
Diane E. Cole United States 24 661 0.9× 912 1.3× 338 1.5× 95 0.4× 56 0.3× 55 2.2k

Countries citing papers authored by Thomas Licht

Since Specialization
Citations

This map shows the geographic impact of Thomas Licht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Licht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Licht more than expected).

Fields of papers citing papers by Thomas Licht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Licht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Licht. The network helps show where Thomas Licht may publish in the future.

Co-authorship network of co-authors of Thomas Licht

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Licht. A scholar is included among the top collaborators of Thomas Licht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Licht. Thomas Licht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riedl, David, Jens Lehmann, Daniel Dejaco, et al.. (2023). Usability of Electronic Patient-Reported Outcome Measures for Older Patients With Cancer: Secondary Analysis of Data from an Observational Single Center Study. Journal of Medical Internet Research. 25. e49476–e49476. 13 indexed citations
2.
3.
Verbeek, Mareike, Falko Fend, Thomas Licht, et al.. (2010). T-cell lymphoproliferative disorder potentially induced by imatinib in a patient with GIST. Nature Reviews Clinical Oncology. 7(2). 116–119.
4.
Duque‐Afonso, Jesús, Michaela Wagner, Michael Lübbert, et al.. (2009). Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes. Clinical Cancer Research. 15(11). 3705–3715. 97 indexed citations
5.
Wienecke, Ralf, et al.. (2006). Antitumoral Activity of Rapamycin in Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex. American Journal of Kidney Diseases. 48(3). e27–e29. 97 indexed citations
6.
Link, Thomas M., et al.. (2004). In Vitro and in Vivo Spiral CT to Determine Bone Mineral Density: Initial Experience in Patients at Risk for Osteoporosis. Radiology. 231(3). 805–811. 83 indexed citations
7.
8.
Lübbert, Michael, et al.. (2003). Acute myeloid leukemia of the elderly: results of induction after previous treatment of high-risk myelodysplastic syndrome with a demethylating agent. FreiDok plus (Universitätsbibliothek Freiburg). 1 indexed citations
9.
Nieder, Carsten, Thomas Licht, Nicolaus Andratschke, Christian Peschel, & M. Molls. (2003). Influence of differing radiotherapy strategies on treatment results in diffuse large-cell lymphoma: a review. Cancer Treatment Reviews. 29(1). 11–19. 18 indexed citations
10.
Früehauf, Stefan, Marlon R. Veldwijk, Nadežda Basara, et al.. (2002). Gene Therapy for Sarcoma. Cells Tissues Organs. 172(2). 133–144. 10 indexed citations
11.
Licht, Thomas, et al.. (2002). Restoration of Transgene Expression in Hematopoietic Cells with Drug-Selectable Marker Genes. Current Gene Therapy. 2(2). 227–234. 5 indexed citations
12.
Berger, F G, Davide Soligo, K. Schwarz, et al.. (2001). Efficient retrovirus-mediated transduction of primitive human peripheral blood progenitor cells in stroma-free suspension culture. Gene Therapy. 8(9). 687–696. 2 indexed citations
13.
Hafkemeyer, Peter, Thomas Licht, Ira Pastan, & Michael M. Gottesman. (2000). Chemoprotection of Hematopoietic Cells by a Mutant P-Glycoprotein Resistant to a Potent Chemosensitizer of Multidrug-Resistant Cancers. Human Gene Therapy. 11(4). 555–565. 13 indexed citations
14.
Gottesman, Michael M., Carol Cardarelli, Sarah Goldenberg, Thomas Licht, & Ira Pastan. (1998). [17] Selection and maintenance of multidrug-resistant cells. Methods in enzymology on CD-ROM/Methods in enzymology. 292. 248–258. 15 indexed citations
15.
Licht, Thomas, Michael M. Gottesman, & Ira Pastan. (1998). [41] Retroviral transfer of multidrug transporter to murine hematopoietic stem cells. Methods in enzymology on CD-ROM/Methods in enzymology. 292. 546–557. 1 indexed citations
16.
Veelken, Hendrik, Thomas Licht, Gabriele Köhler, et al.. (1998). Drug resistance of secondary acute myeloid leukemia with megakaryoblastic features and p190 BCR-ABL rearrangement. Leukemia Research. 22(11). 1021–1027. 5 indexed citations
17.
Licht, Thomas, Ira Pastan, Michael M. Gottesman, & F. Herrmann. (1996). The multidrug-resistance gene in gene therapy of cancer and hematopoietic disorders. Annals of Hematology. 72(4). 184–193. 15 indexed citations
18.
Hwang, Myung-Sil, Chang‐Ho Ahn, P. Scott Pine, et al.. (1996). Effect of combination of suboptimal concentrations of P-glycoprotein blockers on the proliferation ofMDR1 gene expressing cells. International Journal of Cancer. 65(3). 389–397. 21 indexed citations
19.
Germann, Ursula A., Timothy C. Chambers, Suresh V. Ambudkar, et al.. (1996). Characterization of Phosphorylation-defective Mutants of Human P-glycoprotein Expressed in Mammalian Cells. Journal of Biological Chemistry. 271(3). 1708–1716. 149 indexed citations
20.
Licht, Thomas, et al.. (1992). Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase? in human tumour lines: implications for in vitro chemoresistance. Journal of Cancer Research and Clinical Oncology. 118(2). 116–122. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew L. Gilman Breakdown of academic impact, for papers by E Archimbaud Breakdown of academic impact, for papers by Martin Höglund Breakdown of academic impact, for papers by Michael Loughnan Breakdown of academic impact, for papers by Giuliana Alimena Breakdown of academic impact, for papers by Tanya Trippett Breakdown of academic impact, for papers by Hiroaki Goto Breakdown of academic impact, for papers by Michael E. Ross Breakdown of academic impact, for papers by P H Wiernik Breakdown of academic impact, for papers by Diane E. Cole
Rankless by CCL
2026